Source: Nuventra Vimeo Channel

Nuventra posted a video "Navigating Regulatory Strategies for Cellular & Gene Therapies" on VIMEO

This webinar covers key regulatory strategies important to first-in-human trials for cellular and gene therapies. While any drug development program can face regulatory hurdles, developing cellular and gene therapies often presents unique challenges.At the end of this webinar attendees should have a better understanding of:1. Regulatory requirements to initiate clinical trials for cellular and gene therapy submissions in the US and EU.2. Differences in product submissions for cellular and gene therapies vs. small molecule drugs.3. How to apply the Target Product Profile to guide product development.

See Video »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Geoffrey Banks's photo - CEO of Nuventra

CEO

Geoffrey Banks

CEO Approval Rating

90/100

Read more